Does the TLR3 rs3775291 TT genotype reduce TLR3 signaling and type I interferon responses?

Toll-like receptor 3 (TLR3) is a critical component of the innate immune system, specifically responsible for detecting double-stranded RNA (dsRNA), a molecular signature of many viral infections. The rs3775291 polymorphism (specifically the TT genotype, resulting in the L412F missense mutation) significantly alters the structural integrity and functionality of this receptor.

Mechanistic impact on TLR3 signaling

The rs3775291 TT genotype encodes a phenylalanine substitution for leucine at position 412 (L412F) within the receptor’s ectodomain. This structural change has profound effects on the protein’s behavior:

• Structural Disruption: The substitution disrupts the packing of leucine-rich repeats (LRR), which are essential for receptor dimerization and ligand binding.
• Defective Trafficking: The variant protein exhibits impaired intracellular trafficking, failing to localize efficiently to the endosomes—the primary site where TLR3 encounters viral dsRNA.
• Pathway Failure: Because the receptor cannot dimerize or localize properly, it fails to activate the TRIF-dependent signaling pathway. This prevents the necessary activation of transcription factors, specifically Interferon Regulatory Factor 3 (IRF3), which is the primary driver of interferon production.

Effect on Type I interferon responses

The functional consequence of the TT genotype is a significant "hyporesponsive" phenotype when exposed to viral triggers:

• Reduced IFN-β Production: In vitro assays using cells homozygous for the T allele (TT genotype) show a substantial reduction in IFN-β and NF-κB activity—often reaching a 50% or greater decrease compared to the wild-type (CC genotype).
• Systemic Consequences: This reduction in Type I interferons (IFN-α and IFN-β) weakens the immediate antiviral state of neighboring cells, often leading to higher viral loads and increased susceptibility to severe outcomes in infections like SARS-CoV-2 and BK polyomavirus.
• Immune Dampening: While this hyporesponsiveness may offer some protection against hyper-inflammatory states in specific contexts (like chronic graft-versus-host disease), it generally correlates with a weakened defense against primary viral challenges.

Bottom line

The TLR3 rs3775291 TT genotype is a well-characterized loss-of-function variant. It results in structural and trafficking defects that significantly impair TLR3 signaling, leading to a markedly weaker Type I interferon response when the body encounters viral dsRNA.